AstraZeneca today announced that the German reimbursement body, the Federal Joint Committee (G-BA), has published the Institute for Quality and Efficiency in Healthcare (IQWiG) preliminary assessment report regarding the medical benefit of BRILIQUE (ticagrelor).

Merck (NYSE: MRK), known as MSD outside the United States and Canada, launched its 2010 global corporate responsibility report, which emphasizes the importance of discovering better ways of doing business to benefit both society and its business.

Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced it has completed its acquisition of Nycomed A/S ("Nycomed") for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda effective the same day.

Pfizer Inc. (NYSE: PFE) and the National Association of Boards of Pharmacy® (NABP) are launching a new effort to draw attention to the risks associated with counterfeit prescription medicines and help patients learn how to safely buy medicines online.

Eli Lilly and Company (NYSE: LLY) announced the launch of a new open innovation platform designed to help build the company's pipeline of tomorrow and, from a philanthropic perspective, identify molecules that may have application for treating multi-drug resistant tuberculosis (MDR-TB).

Merck KGaA announced today that it has published a new brochure depicting how the company successfully transforms new ideas into innovative products, services and processes. The brochure concisely presents Merck innovations in pharmaceuticals, chemicals and life sciences that help to improve quality of life.

Sanofi (EURONEXT: SAN and NYSE: SNY) announces that it has successfully priced its offering of USD 1 billion of notes denominated in US dollars, due 2014, bearing interest at an annual rate of 1.20%.